Case Study: ProteinSimple uses the Intel® NUC to power Wes*, an automated Western blot protein analysis solution that takes less space and time.
Case Study: ProteinSimple uses the Intel® Core™ i5 processor-based Intel® NUC to power Wes*, an automated Western blot protein analysis solution that takes less space and time, so analysts and technicians can focus on research and discovery.
Infographic: See how the new Ultrabook™ 2 in 1 executive PC powered by the 6th gen Intel® Core™ vPro™ processor can make your workday great.
Infographic: Find out how the new Ultrabook™ 2 in 1 executive PC powered by the 6th generation Intel® Core™ vPro™ processor can make your workday great with fast logins, more productivity, and the battery power to go the distance.
Case Study: GenoSpace Population Analytics* application accelerates encryption performance with Intel® Advanced Encryption Standard New Instructions.
Case Study: GenoSpace accelerates the encryption and decryption performance of its Population Analytics* application to safeguard healthcare data confidentiality with the Intel® Advanced Encryption Standard New Instructions.
White paper: Examine the value of big data utilization in the Japanese healthcare industry.
White paper: Professor Sawa of Teikyo University explains the value of big data utilization in healthcare and advances made with solutions from Intel.
High-performance computing, domain expertise, and Intel’s application expertise help demonstrate next-gen sequencing as a personalized medicine tool.
High-performance computing infrastructure, domain expertise, Dell’s financial support, and Intel’s application expertise helped a molecular guided therapy cancer study demonstrate next-gen sequencing as a tool for personalized medicine.
Solution brief: Ayasdi boosts software application performance of topological data analysis and machine learning on the Intel® Xeon® processor E5 v3 family and Intel® SSDs, delivering faster critical intelligence to leading enterprises.
Case Study: The Human Genome Center researches personalized genomic medicine for cancer using an Intel® Xeon® processor E5 family-powered supercomputer running Intel® Enterprise Edition for Lustre* software for whole-genome sequencing and analysis.